1. Home
  2. ETON vs PSBD Comparison

ETON vs PSBD Comparison

Compare ETON & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • PSBD
  • Stock Information
  • Founded
  • ETON 2017
  • PSBD 2009
  • Country
  • ETON United States
  • PSBD United States
  • Employees
  • ETON N/A
  • PSBD N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • PSBD
  • Sector
  • ETON Health Care
  • PSBD
  • Exchange
  • ETON Nasdaq
  • PSBD Nasdaq
  • Market Cap
  • ETON 428.5M
  • PSBD 462.9M
  • IPO Year
  • ETON 2018
  • PSBD 2024
  • Fundamental
  • Price
  • ETON $13.75
  • PSBD $14.59
  • Analyst Decision
  • ETON Strong Buy
  • PSBD Buy
  • Analyst Count
  • ETON 3
  • PSBD 4
  • Target Price
  • ETON $29.67
  • PSBD $14.13
  • AVG Volume (30 Days)
  • ETON 457.7K
  • PSBD 45.0K
  • Earning Date
  • ETON 08-07-2025
  • PSBD 08-07-2025
  • Dividend Yield
  • ETON N/A
  • PSBD 12.33%
  • EPS Growth
  • ETON N/A
  • PSBD N/A
  • EPS
  • ETON N/A
  • PSBD N/A
  • Revenue
  • ETON $48,327,000.00
  • PSBD N/A
  • Revenue This Year
  • ETON $103.21
  • PSBD N/A
  • Revenue Next Year
  • ETON $51.34
  • PSBD N/A
  • P/E Ratio
  • ETON N/A
  • PSBD N/A
  • Revenue Growth
  • ETON 40.88
  • PSBD N/A
  • 52 Week Low
  • ETON $3.19
  • PSBD $11.51
  • 52 Week High
  • ETON $21.48
  • PSBD $16.85
  • Technical
  • Relative Strength Index (RSI)
  • ETON 26.60
  • PSBD 63.29
  • Support Level
  • ETON $13.09
  • PSBD $14.48
  • Resistance Level
  • ETON $14.18
  • PSBD $14.98
  • Average True Range (ATR)
  • ETON 0.78
  • PSBD 0.31
  • MACD
  • ETON -0.23
  • PSBD 0.02
  • Stochastic Oscillator
  • ETON 8.78
  • PSBD 68.57

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: